3-[[4-[2-[5-Chloro-1-(4-chlorophenyl)indole-2-carbonyl]pentyl]benzoyl]amino]propanoic acid | 934613-72-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 英文名称: 3-[[4-[2-[5-Chloro-1-(4-chlorophenyl)indole-2-carbonyl]pentyl]benzoyl]amino]propanoic acid
• CAS: 934613-72-6
• 化学式: C₃₀H₂₈Cl₂N₂O₄
• 分子量: 551.469
• InChiKey: SLVCGBAXQWWREW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.1
• 重原子数：
  38
• 可旋转键数：
  11
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  88.4
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  在 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 生成 3-[[4-[2-[5-Chloro-1-(4-chlorophenyl)indole-2-carbonyl]pentyl]benzoyl]amino]propanoic acid
  参考文献：
  名称：

  Discovery of N-Aryl-2-acylindole human glucagon receptor antagonists

  摘要：

  A novel class of N-aryl-2-acylindole human glucagon receptor (hGCGR) antagonists is reported. These compounds demonstrate good pharmacokinetic profiles in multiple preclinical species. One compound from this series, indole 33, is orally active in a transgenic murine pharmacodynamic model. Furthermore, a 1 mg/kg oral dose of indole 33 lowers ambient glucose levels in an ob/ob/hGCGR transgenic murine diabetes model. This compound was deemed suitable for preclinical safety studies and was found to be well tolerated in an 8-day experimental rodent tolerability study. The combination of preclinical efficacy and safety observed with compound 33 highlights the potential of this class as a treatment for type 2 diabetes. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.09.105